Moderna
MRNA
#894
Rank
S$35.73 B
Marketcap
S$90.07
Share price
3.61%
Change (1 day)
155.88%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$35.73 Billion

As of June 2026 Moderna has a market cap of S$35.73 Billion. This makes Moderna the world's 894th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$35.73 B128.34%
2025S$15.65 B-25.43%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Moderna was reported to be:

S$34.49 Billion
by Nasdaq info icon info icon
S$34.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$804.17 B 2,150.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$388.58 B 987.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$412.94 B 1,055.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.73 B-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.84 B-89.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.07 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$50.64 B 41.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$14.65 B-59.00%๐Ÿ‡บ๐Ÿ‡ธ USA